whitepaper

Whitepaper: Addressing the challenges in biologics discovery with advanced flow cytometry

Posted: 22 June 2020 | | No comments yet

Biologics represent a growing class of drugs with indications in oncology, chronic inflammation, and autoimmune diseases.

However, development and production of biopharmaceuticals is expensive, time consuming, and requires a great deal of expertise.

Flow cytometry is an attractive tool for use in biopharma due to its ability to simultaneously check multiple parameters however it has few key limitations such as:

  • Low Assay throughput
  • Limited automated data analysis capabilities
  • High sample/reagent volume requirements

In this whitepaper, discover how advanced flow cytometry can address these challenges and simplify complex workflows to deliver actionable insights.











    To read this whitepaper in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


    *

    *

    *

    *

    *


    *

    *

    *

    *

    Are you interested in purchasing an advanced high throughput flow cytometry platform?

    Yes, in 0-3 monthsYes, in 3-6 monthsYes, in 6-12 monthsYes, in more than 12 monthsNo intent to purchase

     

    This content is provided to you for free thanks to the kind support of our sponsor: IntelliCyt Corporation

    Send this to a friend